REV 5901 是一种竞争性和具有口服活性的白三烯受体 (leukotriene receptor) 拮抗剂，Ki值为 0.7 μM。REV 5901 也是一种 5-脂氧合酶 (5-lipoxygenase) 抑制剂。REV 5901 可用于涉及白三烯释放的哮喘研究。
| 生物活性 | REV 5901 is a competitive and orally active antagonist ofleukotriene receptor, with aKiof 0.7 μM. REV 5901 is also a5-lipoxygenaseinhibitor. REV 5901 can be used for the research of asthma in which leukotriene release be involved[1][2]. |
| IC50& Target | Ki: 0.7 μM (leukotriene receptor)[1]
[2] |
| 分子量 | |
| Formula | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
